Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia

about

Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia

Item

http://www.wikidata.org/entity/Q57812045

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Active surveillance of 2017 se ...... months and older in Australia

@en

Active surveillance of 2017 se ...... months and older in Australia

@nl

type

Item

label

Active surveillance of 2017 se ...... months and older in Australia

@en

Active surveillance of 2017 se ...... months and older in Australia

@nl

prefLabel

Active surveillance of 2017 se ...... months and older in Australia

@en

Active surveillance of 2017 se ...... months and older in Australia

@nl

P1476

Active surveillance of 2017 se ...... months and older in Australia

@en

P2093

Alan Leeb

http://www.w3.org/2001/XMLSchema#string

Alexis J Pillsbury

http://www.w3.org/2001/XMLSchema#string

Catherine Glover

http://www.w3.org/2001/XMLSchema#string

Helen E Quinn

http://www.w3.org/2001/XMLSchema#string

Kristine K Macartney

http://www.w3.org/2001/XMLSchema#string

Michael S Gold

http://www.w3.org/2001/XMLSchema#string

Patrick Cashman

http://www.w3.org/2001/XMLSchema#string

Peter Jacoby

http://www.w3.org/2001/XMLSchema#string

P2860

Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children.

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine.

An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination

Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16.

Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults.

P304

e023263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2018-023263

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Blyth

Tom Snelling

Parveen Fathima

P577

2018-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30341132

http://www.w3.org/2001/XMLSchema#string

P932

6196842

http://www.w3.org/2001/XMLSchema#string